Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

Andrew Branagan (Massachusetts General Hospital, United States) Clifton Mo (Dana-Farber Cancer Institute, Harvard Medical School, United States) Matthew Lei (Massachusetts General Hospital Cancer Center, United States) Joshua Gustine (, United States) Andrew Yee (Massachusetts General Hospital Cancer Center, United States) Elizabeth O’Donnell (Massachusetts General Hospital, ) Jorge Castillo (Dana-Farber Cancer Institute, United States) Omar Nadeem (Dana-Farber Cancer Institute, United States) Catherine Flynn (Dana Farber Cancer Institute, United States) Zachary Bernstein (Massachusetts General Hospital Cancer Center, United States) Rie Nakamoto-Matsubara (Massachusetts General Hospital Cancer Center, United States) Kirsten Meid (Dana Farber Cancer Institute, United States) Rakesh Verma (Massachusetts General Hospital, Harvard Medical School, United States) Zachary Hunter (Dana Farber Cancer Institute, United States) Maria Luisa Guerrera (Dana Farber Cancer Institute, United States) Galit Alter (Ragon Institute of Mass General, MIT, and Harvard, United States) Jill Burke (Massachusetts General Hospital Cancer Center, United States) Cynthia Harrington (Massachusetts General Hospital Cancer Center, United States) Emerentia Agyemang (Massachusetts General Hospital, United States) Marilyn Gammon (Massachusetts General Hospital Cancer Center, United States) Kathleen Lively (Massachusetts General Hospital Cancer Center, United States) Lisette Packer (Massachusetts General Hospital Cancer Center, United States) Nora Horick (Massachusetts General Hospital, United States) Jacob Laubach (Dana-Farber Cancer Institute, United States) Constantine Mitsiades (Dana-Farber Cancer Institute, Harvard Med. School, United States) Nikhil Munshi (Dana Farber Cancer Institute, United States) Kenneth Anderson (Dana-Farber Cancer Institute, United States) Steven Treon (Dana Farber Cancer Institute, United States) Paul Richardson (Dana-Farber Cancer Institute, Harvard Medical School, United States) Noopur Raje (Massachusetts General Hospital, United States) Shayna Sarosiek (Dana Farber Cancer Institute, United States)

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

American Society of Hematology Blood Advances Tracking no: ADV-2025-016513R1